Immediate Impact
1 from Science/Nature 59 standout
Citing Papers
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
2023 Standout
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
2023 Standout
Works of A Corrias being referenced
Double-blind multicenter study on the efficacy and tolerability of cetirizine compared with oxatomide in chronic idiopathic urticaria in preschool children
2001
Double-blind study of cetirizine in atopic eczema in children.
1994
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| A Corrias | 117 | 74 | 77 | 111 | 17 | 262 | |
| Stanislaus Ting | 142 | 77 | 60 | 111 | 21 | 311 | |
| M. Bourgoin‐Heck | 106 | 52 | 54 | 92 | 25 | 199 | |
| Rafael Pamies | 137 | 80 | 103 | 154 | 12 | 310 | |
| Ayşegül Akan | 117 | 62 | 108 | 132 | 16 | 292 | |
| Yu‐Ling Tu | 189 | 71 | 34 | 116 | 13 | 297 | |
| Claudia Calogero | 109 | 141 | 51 | 42 | 11 | 243 | |
| Kelly Weiss | 149 | 52 | 33 | 67 | 17 | 328 | |
| Amber N. Pepper | 174 | 86 | 50 | 165 | 19 | 323 | |
| Zamir Calamita | 214 | 60 | 121 | 210 | 18 | 305 | |
| Shuko Tokuriki | 52 | 76 | 15 | 51 | 18 | 272 |
All Works
Loading papers...